Contact
Please use this form to send email to PR contact of this press release:
GSK and MMV announce FDA Breakthrough Therapy designation for tafenoquine for Plasmodium vivax malaria
TO:
Please use this form to send email to PR contact of this press release:
GSK and MMV announce FDA Breakthrough Therapy designation for tafenoquine for Plasmodium vivax malaria
TO: